PLX icon

Protalix BioTherapeutics
PLX

Overview Fund Activity

25 hedge funds and large institutions have $18.4M invested in Protalix BioTherapeutics in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 6 closing their positions.

Holders
25
Holders Change
-3
Holders Change %
-10.71%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
9
Reduced
5
Closed
6
Calls
$658K
Puts
$93K
Net Calls
+$565K
Net Calls Change
-$571K

Top Buyers

1
KCM
1
Kennedy Capital Management
Missouri
$577K
2
Squarepoint
2
Squarepoint
New York
$173K
3
BCM
3
Bridgeway Capital Management
Texas
$823K
4
Simplex Trading
4
Simplex Trading
Illinois
$69K
5
PF
5
Phoenix Financial
Israel
$751K

Top Sellers

1
UOC
1
UBS O'Connor
Illinois
$1.16M
2
Jane Street
2
Jane Street
New York
$57K
3
Walleye Capital
3
Walleye Capital
New York
$0
4
Renaissance Technologies
4
Renaissance Technologies
New York
$1.9M
5
Walleye Trading
5
Walleye Trading
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Citadel Advisors
26
Citadel Advisors
Florida
– -$92K -24,047 Closed
CS
27
Credit Suisse
Switzerland
– -$38K -10,000 Closed
SPIA
28
Steward Partners Investment Advisory
New York
– -$1K -200 Closed
1
2